Targeting p53 pathways: mechanisms, structures, and advances in therapy

H Wang, M Guo, H Wei, Y Chen - Signal transduction and targeted …, 2023 - nature.com
The TP53 tumor suppressor is the most frequently altered gene in human cancers, and has
been a major focus of oncology research. The p53 protein is a transcription factor that can …

p53 signaling in cancer progression and therapy

HE Marei, A Althani, N Afifi, A Hasan, T Caceci… - Cancer cell …, 2021 - Springer
The p53 protein is a transcription factor known as the" guardian of the genome" because of
its critical function in preserving genomic integrity. The TP53 gene is mutated in …

The regulation of ferroptosis by tumor suppressor p53 and its pathway

J Liu, C Zhang, J Wang, W Hu, Z Feng - International journal of molecular …, 2020 - mdpi.com
Tumor suppressor p53 plays a key role in tumor suppression. In addition to tumor
suppression, p53 is also involved in many other biological and pathological processes, such …

Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways

Z Zhu, AJR McGray, W Jiang, B Lu, P Kalinski, ZS Guo - Molecular cancer, 2022 - Springer
Oncolytic viruses (OVs) represent a new class of multi-modal immunotherapies for cancer,
with OV-elicited antitumor immunity being key to their overall therapeutic efficacy. Currently …

p53 at the crossroads of tumor immunity

G Efe, AK Rustgi, C Prives - Nature Cancer, 2024 - nature.com
The p53 tumor suppressor protein has a plethora of cell-intrinsic functions and
consequences that impact diverse cell types and tissues. Recent studies are beginning to …

Translating p53-based therapies for cancer into the clinic

S Peuget, X Zhou, G Selivanova - Nature Reviews Cancer, 2024 - nature.com
Inactivation of the most important tumour suppressor gene TP53 occurs in most, if not all,
human cancers. Loss of functional wild-type p53 is achieved via two main mechanisms …

The role of p53 in anti-tumor immunity and response to immunotherapy

L Carlsen, S Zhang, X Tian, A De La Cruz… - Frontiers in Molecular …, 2023 - frontiersin.org
p53 is a transcription factor that regulates the expression of genes involved in tumor
suppression. p53 mutations mediate tumorigenesis and occur in approximately 50% of …

The role of p53 dysfunction in colorectal cancer and its implication for therapy

M Michel, L Kaps, A Maderer, PR Galle, M Moehler - Cancers, 2021 - mdpi.com
Simple Summary Despite remarkable progress being made by preventive medical check-
ups in the last decades, colorectal cancer (CRC) remains one of the most frequent and …

Targeting mutant p53 for cancer treatment: moving closer to clinical use?

MJ Duffy, M Tang, S Rajaram, S O'Grady, J Crown - Cancers, 2022 - mdpi.com
Simple Summary Cancer is largely caused by genetic alterations such as mutations in a
group of genes known as cancer driver genes. Many of the key advances in cancer …

The role of p53 in progression of cutaneous squamous cell carcinoma

M Piipponen, P Riihilä, L Nissinen, VM Kähäri - Cancers, 2021 - mdpi.com
Simple Summary Skin cancers are the most common types of cancer worldwide, and their
incidence is increasing. Epidermal keratinocyte-derived cutaneous squamous cell …